Announcement of the board approved of the 2021 consolidated financial reports
· Issued by Standard Chemical & Pharmaceutical Co. Ltd.
Close
Today's Information
Provided by: Standard Chemical & Pharmaceutical Co. Ltd.
SEQ_NO
1
Date of announcement
2022/04/08
Time of announcement
15:18:50
Subject
Announcement of the board approved of the
2021 consolidated financial reports
Date of events
2022/03/15
To which item it meets
paragraph 31
Statement
1.Date of submission to the board of directors or approval by the board of
directors:2022/03/15
2.Date of approval by the audit committee:2022/03/15
3.Start and end dates of financial reports or annual self-assessed financial
information of the reporting period (XXXX/XX/XX~XXXX/XX/XX):
2021/1/1~2021/12/31
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):4604082
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):2067873
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):876682
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):1013750
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):836802
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):706734
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):3.95
11.Total assets end of the period (thousand NTD):10104021
12.Total liabilities end of the period
(thousand NTD):3304407
13.Equity attributable to owners of parent end of the
period (thousand NTD):4341876
14.Any other matters that need to be specified:NA
